Office of the Director, National Institutes of Health; Notice of Meeting, 51844 [2023-16685]
Download as PDF
<![CDATA[
51844
Federal Register / Vol. 88, No. 149 / Friday, August 4, 2023 / Notices
previously approved FDA collections of
information. Therefore, clearance by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995 (PRA) (44 U.S.C. 3501–
3521) is not required for this guidance.
The previously approved collections of
information are subject to review by
OMB under the PRA. The collections of
information in ‘‘Waivers, Exceptions,
and Exemptions from the Requirements
of section 582 of the Federal Food, Drug,
and Cosmetic Act’’ have been approved
under OMB control number 0910–0806.
III. Electronic Access
Persons with access to the internet
may obtain the guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
vaccines-blood-biologics/guidancecompliance-regulatory-informationbiologics/biologics-guidances, https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents, or
https://www.regulations.gov.
Dated: July 31, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–16645 Filed 8–3–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Novel and Exceptional
Technology and Research Advisory
Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting should notify the Contact
Person listed below in advance of the
meeting. The meeting will be videocast
and can be accessed from the NIH
Videocasting and Podcasting website
(https://videocast.nih.gov/).
Name of Committee: Novel and
Exceptional Technology and Research
Advisory Committee.
Date: August 29, 2023.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: The Novel and Exceptional
Technology and Research Advisory
Committee meeting will include
presentation, discussion, and possible
finalization of the Draft Report of the
VerDate Sep<11>2014
18:51 Aug 03, 2023
Jkt 259001
Working Group on Data Science and
Emerging Technology and will include
discussion of next steps for the Committee.
Place: National Institutes of Health, 6705
Rockledge Drive, Suite 630, Bethesda, MD
20892 (Virtual Meeting Link will be available
at https://osp.od.nih.gov/policies/novel-andexceptional-technology-and-researchadvisory-committee-nextrac#tab4/).
Contact Person: Jessica Tucker, Ph.D.,
Office of Science Policy, National Institutes
of Health, 6705 Rockledge Drive, Suite 630,
Bethesda, MD 20892, 301–496–9838,
SciencePolicy@od.nih.gov.
Members of the public may request to
make an oral public comment or may submit
written public comments. To sign up to make
an oral public comment, please submit your
name, affiliation, and short description of the
oral comment to the Contact Person listed on
this notice at least two business days prior
to the meeting date. Once all time slots are
filled, only written comments will be
accepted. Any interested person may file
written comments by forwarding the
statement to the Contact Person listed on this
notice at least two business days prior to the
meeting date. The statement should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person. Other
than name and contact information, please
do not include any personally identifiable
information or any information that you do
not wish to make public. Proprietary,
classified, confidential, or sensitive
information should not be included in your
comments. Please note that any comments
NIH receives may be posted unredacted to
the Office of Science Policy website.
Information is also available on the NIH
Office of Science Policy website: https://
osp.od.nih.gov/policies/novel-andexceptional-technology-and-researchadvisory-committee-nextrac#tab4, where an
agenda, link to the webcast meeting, and any
additional information for the meeting will
be posted when available. Materials for this
meeting will be posted prior to the meeting.
Please check this website for updates.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: August 1, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–16685 Filed 8–3–23; 8:45 am]
Frm 00078
Fmt 4703
Substance Abuse and Mental Health
Services Administration
Tribal Listening Session and Tribal
Consultation; Notice of Meeting
Change
Substance Abuse and Mental
Health Services Administration
(SAMHSA).
ACTION: Notice of change to tribal
consultation.
AGENCY:
Notice is given that the
August 29, 2023, virtual meeting
SAMHSA Tribal Consultation that was
published in the Federal Register on
July 11, 2023, (Document Number 2023–
14638; pages 44134–4135), will now be
a Tribal Listening Session. SAMHSA
will host American Indian and Alaska
Native (AI/AN) Federally Recognized
Tribes for a virtual Tribal listening
session on the BEHAVIORAL HEALTH
AND SUBSTANCE USE DISORDER
RESOURCES FOR NATIVE
AMERICANS PROGRAM.
DATES: The virtual SAMHSA Tribal
Listening Session will be held on
August 29, 2023, from 4:00 p.m.–6:00
p.m. EDT. Registration is required at:
https://www.zoomgov.com/meeting/
register/vJItfuitqDIvGJb7z8G5vUTNjXjFDxOG8U. Individuals
must register to obtain the call-in
number, access code, and/or web access
link or request special accommodations
for those with disabilities.
Instructions to access the Zoom
virtual consultation will be provided in
the above link following registration.
FOR FURTHER INFORMATION CONTACT:
CAPT Karen Hearod, MSW, LCSW,
Director, Office of Tribal Affairs and
Policy, Substance Abuse and Mental
Health Services Administration,
Telephone: (202) 868–9931, Email:
otap@samhsa.hhs.gov.
SUMMARY:
Dated: July 6, 2023.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2023–16666 Filed 8–3–23; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2023–0247]
Certificates of Alternative Compliance
for the Eighth Coast Guard District
AGENCY:
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sfmt 4703
E:\FR\FM\04AUN1.SGM
Coast Guard, DHS.
04AUN1
]]>Agencies
[Federal Register Volume 88, Number 149 (Friday, August 4, 2023)]
[Notices]
[Page 51844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16685]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Novel and
Exceptional Technology and Research Advisory Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting should notify the Contact Person listed below in
advance of the meeting. The meeting will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: August 29, 2023.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee meeting will include presentation, discussion,
and possible finalization of the Draft Report of the Working Group
on Data Science and Emerging Technology and will include discussion
of next steps for the Committee.
Place: National Institutes of Health, 6705 Rockledge Drive,
Suite 630, Bethesda, MD 20892 (Virtual Meeting Link will be
available at https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4/).
Contact Person: Jessica Tucker, Ph.D., Office of Science Policy,
National Institutes of Health, 6705 Rockledge Drive, Suite 630,
Bethesda, MD 20892, 301-496-9838, [email protected].
Members of the public may request to make an oral public comment
or may submit written public comments. To sign up to make an oral
public comment, please submit your name, affiliation, and short
description of the oral comment to the Contact Person listed on this
notice at least two business days prior to the meeting date. Once
all time slots are filled, only written comments will be accepted.
Any interested person may file written comments by forwarding the
statement to the Contact Person listed on this notice at least two
business days prior to the meeting date. The statement should
include the name, address, telephone number and, when applicable,
the business or professional affiliation of the interested person.
Other than name and contact information, please do not include any
personally identifiable information or any information that you do
not wish to make public. Proprietary, classified, confidential, or
sensitive information should not be included in your comments.
Please note that any comments NIH receives may be posted unredacted
to the Office of Science Policy website.
Information is also available on the NIH Office of Science
Policy website: https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4,
where an agenda, link to the webcast meeting, and any additional
information for the meeting will be posted when available. Materials
for this meeting will be posted prior to the meeting. Please check
this website for updates.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: August 1, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-16685 Filed 8-3-23; 8:45 am]
BILLING CODE 4140-01-P
